NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 47 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8 | -99.9% | 16,246 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -65.6% | 16,246 | -50.0% | 0.00% | – |
| Q2 2022 | $32,000 | +10.3% | 32,492 | +109.6% | 0.00% | – |
| Q1 2022 | $29,000 | -60.8% | 15,500 | +1.7% | 0.00% | – |
| Q4 2021 | $74,000 | -35.1% | 15,247 | -1.6% | 0.00% | – |
| Q3 2021 | $114,000 | -21.4% | 15,500 | 0.0% | 0.00% | – |
| Q2 2021 | $145,000 | -23.7% | 15,500 | 0.0% | 0.00% | – |
| Q1 2021 | $190,000 | -14.0% | 15,500 | 0.0% | 0.00% | – |
| Q4 2020 | $221,000 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
| Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
| Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
| Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
| Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
| Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
| Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
| Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |